Stay updated with breaking news from Applied Dna Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright restated their buy rating on shares of Applied DNA Sciences (NASDAQ:APDN – Get Rating) in a research report sent to investors on Thursday, Benzinga reports. They currently have a $5.00 price objective on the technology company’s stock. Other research analysts have also recently issued research reports about the company. Maxim Group cut their […]
StockNews.com upgraded shares of Applied DNA Sciences (NASDAQ:APDN – Get Rating) from a sell rating to a hold rating in a research report released on Thursday morning. Several other research firms have also recently weighed in on APDN. Maxim Group decreased their target price on Applied DNA Sciences from $6.00 to $3.00 in a research […]
- Maintains Timeline to cGMP Capacity, Initiates Build-out of Cost-Efficient Facility - - Business Update Conference Call/Webcast Scheduled for Today at 4:30 PM ET - ... | February 9, 2023
Applied DNA Sciences, Inc. announced that it received its large single purchase order for LinearDNA™ valued above the mid-six-figures. The order was placed under a long-standing supply... | October 11, 2022
07.09.2022 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference on ...